ArticleExperimental and therapeutic medicine2026
Multiple relapses of cryptogenic organizing pneumonia: A case report.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cryptogenic organizing pneumonia (COP) is an important subtype of idiopathic interstitial pneumonia, triggered by abnormal inflammatory responses of the lung to unknown stimuli. The disease shows good initial sensitivity to glucocorticoid therapy, but ~50% of patients experience recurrence after glucocorticoid dose reduction or withdrawal. Cases of multiple recurrences (≥3 times) are rarely reported clinically, and no unified consensus has been formed on their diagnosis and treatment strategies, making clinical management challenging. In the present study, a 53-year-old female patient was admitted to hospital for the first time, presenting with a recurrent cough for >1 month. Chest computed tomography (CT) revealed multiple areas of increased density in both lungs, with no notable absorption of the lesions following antimicrobial therapy. A CT-guided percutaneous lung biopsy revealed widened alveolar septa with numerous fibroblast clusters and foam cells within the alveolar spaces, consistent with a diagnosis of COP. Following treatment with methylprednisolone combined with anti-infective therapy, the lesions largely resolved. The patient was discharged on a tapering regimen of oral prednisone, completing a total treatment course of 2 months. After discontinuing medication for 18 months, the patient was readmitted due to chest tightness. CT revealed recurrence of the bilateral pulmonary lesions. Treatment with methylprednisolone combined with anti-infective therapy was administered. Following discharge, oral methylprednisolone therapy for 5 months resulted in complete resolution of the lesions. After 16 months of low-dose oral methylprednisolone maintenance therapy, the patient presented for a third visit with a cough and chest tightness. Chest CT confirmed recurrence of the COP. Symptoms improved after oral prednisone administration, but radiographic changes remained minimal. Multiple recurrent COP has clinical characteristics of migratory lesions, glucocorticoid sensitivity and easy recurrence, and a pathological biopsy is the key to its diagnosis. Long-term glucocorticoid maintenance and individualized dose reduction regimens may reduce the risk of recurrence, but the optimal treatment plan still needs to be explored in further clinical studies. The present case can provide a practical reference for the diagnosis and treatment of multiple recurrent COP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.